Having a good spokesman’s for this company is completely different than having a new CEO or BOD. All the behind the scenes work is being done very well. CYDY is improving its position each day, week and month on the worldwide stage. This is a small company trying to transition quickly into a big pharma with all that leronlimab can be used for. Bruce and crew are not going to be any improvement over current management at this stage in the game as many others have said any major change would actually be a very big negative to distrust all the actions already in motion. If these guys want to help and believe In the drug let them buy 20% more of the company so that they have more votes at least then they would be putting their money where there mouth is. This would lead to a much higher current SP. These 6% group is nothing more than a distraction and the fact that they had to drag BP into it because they though many investors would Jump at hearing his name but they were sorely wrong.